Cellular aging, senescence, resilience, and longevity-related pathways under study.
33 results
Blend · 3 components
Researchers are studying this blend in relation to cellular aging and senescence pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Blend · 4 components
Research interest in this blend centres on longevity-associated signaling and cellular resilience.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Blend · 4 components
Researchers are studying this blend in relation to cellular aging and senescence pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Blend · 3 components
This blend is examined in studies of whole-body aging and repair-capacity pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Individual peptide
Researchers are studying Cardiogen in relation to cellular aging and senescence pathways.
Level 2 · Animal Research
Claim: Cellular aging and longevity pathways
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Animal and cell bioregulator studies from a limited research group.
View evidence map →Individual peptide
Researchers are studying Cartalax in relation to cellular aging and senescence pathways.
Level 1 · Laboratory Research
Claim: Cellular aging and longevity pathways
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Laboratory bioregulator work only.
View evidence map →Individual peptide
Researchers are studying Cortagen in relation to cellular aging and senescence pathways.
Level 2 · Animal Research
Claim: Cellular aging and longevity pathways
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Animal and cell bioregulator studies from a limited research group.
View evidence map →Individual peptide
Research interest in Crystagen centres on longevity-associated signaling and cellular resilience.
Level 1 · Laboratory Research
Claim: Cellular aging and longevity pathways
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Laboratory bioregulator work only.
View evidence map →Individual peptide
Epithalon is examined in studies of whole-body aging and repair-capacity pathways.
Level 3 · Early Human Research
Claim: Cellular aging and longevity pathways
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Small human studies, largely from a single research group.
View evidence map →Individual peptide
Researchers are studying FOXO4 in relation to cellular aging and senescence pathways.
Level 1 · Laboratory Research
Claim: Cellular aging and longevity pathways
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Cell-model senescence research only.
View evidence map →Individual peptide
Researchers are studying GHK basic in relation to cellular aging and senescence pathways.
Level 1 · Laboratory Research
Claim: Cellular aging and longevity pathways
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Cell and tissue studies without the copper complex.
View evidence map →Individual peptide
GHK-Cu is examined in studies of whole-body aging and repair-capacity pathways.
Level 4 · Controlled Human Studies
Claim: Cellular aging and longevity pathways
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Controlled topical skin trials plus extensive laboratory work.
View evidence map →Every result card shows the same five-segment bar. Each level below matches the color of that segment.
Level 1: Laboratory Research
Observed in cells, tissue, or computational models only.
Level 2: Animal Research
Studied in animal models; results often do not transfer to people.
Level 3: Early Human Research
Human research
Small, early-stage, or uncontrolled studies in humans.
Level 4: Controlled Human Studies
Human research
Randomized or otherwise controlled human trials exist.
Level 5: Regulatory Review or Established Clinical Use
Human research
Reviewed by a regulator or established in clinical practice for a specific use.
Evidence is rated by claim—not popularity. More studies do not always mean stronger evidence.
A higher level describes research maturity. It is not a recommendation or endorsement.
Educational information only. Not medical advice.
0 peptides selected
Select up to 6 peptides to compare.